Amdocs (DOX) Cash & Equivalents (2009 - 2026)

Amdocs (DOX) has 18 years of Cash & Equivalents data on file, last reported at $325.0 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $325.0 million, down 6.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $325.0 million (down 6.09% YoY), and the FY2025 annual result was $325.0 million, down 37.51% from the prior year.
• Cash & Equivalents grew to $325.0 million in Q1 2026 per DOX's latest filing, from $247.9 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $709.1 million in Q1 2022 and troughed at $213.8 million in Q4 2024.
• A 5-year average of $428.7 million and a median of $346.1 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents slumped 44.15% in 2024, then rose 15.92% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $492.2 million in 2022, then slipped by 22.21% to $382.9 million in 2023, then tumbled by 44.15% to $213.8 million in 2024, then climbed by 15.92% to $247.9 million in 2025, then jumped by 31.11% to $325.0 million in 2026.
• Business Quant data shows DOX's Cash & Equivalents at $325.0 million in Q1 2026, $247.9 million in Q4 2025, and $325.0 million in Q3 2025.